Early-Stage Companies

 
News Articles for Early-Stage Companies top ^
Significantly Superior Early-Stage Sensitivity Shown versus CA125, Modified ACOG Guidelines or Overall Clinical Assessment in Premenopausal and Postmenopausal Women Planning Surgery WASHINGTON , Nov.
Sign-up for American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillion's OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer investment picks
LONDON--British Sky Broadcasting Group PLC (BSY.LN) said Tuesday it made a $350,000 equity investment in Jaunt, an early-stage technology company based in Palo Alto, California which specializes in video capture and display.
Sign-up for BSkyB Invests in Early-Stage Video Capture Company investment picks
2014/3/6
BURLINGTON, Mass., March 6, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Endurance International Group (NASDAQ:EIGI) , a leading provider of cloud-based platform solutions to help small and medium-sized businesses succeed online, demonstrated its continued commitment to web civility, advising young companies to start with their customers to establish values to help guide them through difficult issues.
Sign-up for Endurance International Group Committed to Web Civility -- Encourages Early Stage Companies to Set Values and Advocate for their Customers investment picks
2014/3/6
iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced image analysis and radiation therapy solutions for the early identification and treatment of cancer, today announced at the 31 st Annual Miami Breast Cancer Conference that more than 1,000 early stage breast cancer patients have been treated with Intraoperative Radiation Therapy (IORT) using the Xoft ® Axxent ® Electronic Brachytherapy System ® .
Sign-up for iCAD Announces More Than 1,000 Early Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy (IORT) Using the Xoft System investment picks
Unilever PLC (UL, ULVR.LN) is in the early stages of exploring a sale of its Slim-Fast business, Sky News reported Wednesday.
Sign-up for Unilever in Early Stages of Considering Slim-Fast Sale -Sky News investment picks
2014/4/6
INDIANAPOLIS , April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif.
Sign-up for Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014 investment picks
2013/11/27
Results of Review¹ by Harley Street and University College Hospital London Presented in Online Edition of 'Radiotherapy and Oncology' (Green Journal) LONDON , Nov.
Sign-up for Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable Alternative to Surgery for Early-Stage Lung Cancer Patients investment picks
2014/4/3
CANTON, Ga., April 3, 2014 (GLOBE NEWSWIRE) -- Blue Water Global Group, Inc. (OTCBB:BLUU) announces that it has repaid early and in full its second Convertible Promissory Note owed to Asher Enterprises, Inc. (" Asher ") with a maturity date of August 12, 2014.
Sign-up for Blue Water Continues to Pay Off Early-Stage Convertible Debt investment picks
Results of a multi-institutional randomized phase II trial (RTOG 0915/NCCTG N0927) presented at the 2013 annual meeting of the American Society for Radiation Oncology (ASTRO) ATLANTA , Sept.
Sign-up for Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer investment picks
NICE's Recommendation of Oncotype DX® Test is an Important Milestone in Delivering Personalized Medicine to More UK Patients REDWOOD CITY, Calif.
Sign-up for NICE Recommends Genomic Health's Oncotype DX® Test To Guide Chemotherapy Treatment Decisions For Qualified Early-Stage Invasive Breast Cancer Patients investment picks
Fourth Head-to-Head Comparison Reveals Important Clinical Distinctions Between Oncotype DX, the Only Test Demonstrated to Predict Chemotherapy Benefit, and Tests Limited to Breast Cancer Prognosis Conference Marks 10th Anniversary of First Oncotype DX Validation Study, Representing a Decade of Progress in Eliminating 'One-Size-Fits-All' Approach to Breast Cancer Treatment REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium investment picks
2014/1/15
Trial Will Compare Investigational Compound's Efficacy and Safety as an Addition to Standard Treatment NORTH CHICAGO, Ill.
Sign-up for AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer investment picks
2014/3/26
CHARLOTTE, N.C. , March 26, 2014 /PRNewswire/ -- Duke Energy (NYSE: DUK) today issued the following statement regarding the company's management and monitoring of its ash basins: For more than a century, Duke Energy has provided safe, reliable and affordable electricity to our customers.
Sign-up for Duke Energy provides update on early stage progress and acceleration of ash basin management efforts investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Early-Stage Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Early Trades  |  Next: Earn Research